Compare RAYMED LABS. with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RAYMED LABS vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    RAYMED LABS AUROBINDO PHARMA RAYMED LABS/
AUROBINDO PHARMA
 
P/E (TTM) x -6.6 6.9 - View Chart
P/BV x - 1.6 - View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 RAYMED LABS   AUROBINDO PHARMA
EQUITY SHARE DATA
    RAYMED LABS
Mar-21
AUROBINDO PHARMA
Mar-21
RAYMED LABS/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs11,023 0.1%   
Low Rs1333 0.3%   
Sales per share (Unadj.) Rs0422.8 0.0%  
Earnings per share (Unadj.) Rs-0.292.0 -0.2%  
Cash flow per share (Unadj.) Rs-0.1110.0 -0.1%  
Dividends per share (Unadj.) Rs04.00 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs-4.8374.3 -1.3%  
Shares outstanding (eoy) m4.27585.94 0.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio xNM1.6-  
Avg P/E ratio x-5.97.4 -80.5%  
P/CF ratio (eoy) x-6.56.2 -104.6%  
Price / Book Value ratio x-0.21.8 -11.0%  
Dividend payout %04.3 0.0%   
Avg Mkt Cap Rs m4397,398 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m035,350 0.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m0247,746 0.0%  
Other income Rs m03,809 0.0%   
Total revenues Rs m0251,555 0.0%   
Gross profit Rs m-181,480 -0.0%  
Depreciation Rs m010,554 0.0%   
Interest Rs m0745 0.0%   
Profit before tax Rs m-173,990 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m020,098 0.0%   
Profit after tax Rs m-153,892 -0.0%  
Gross profit margin %NM32.9- 
Effective tax rate %027.2 0.0%   
Net profit margin %NM21.8- 
BALANCE SHEET DATA
Current assets Rs m1198,235 0.0%   
Current liabilities Rs m23106,652 0.0%   
Net working cap to sales %NM37.0- 
Current ratio x01.9 2.1%  
Inventory Days DaysNM19- 
Debtors Days DaysNM52- 
Net fixed assets Rs m2135,778 0.0%   
Share capital Rs m43586 7.3%   
"Free" reserves Rs m-63218,713 -0.0%   
Net worth Rs m-21219,299 -0.0%   
Long term debt Rs m01,684 0.0%   
Total assets Rs m3334,013 0.0%  
Interest coverage xNM100.3-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x00.7 0.0%   
Return on assets %-27.316.4 -166.9%  
Return on equity %3.424.6 13.6%  
Return on capital %3.433.8 9.9%  
Exports to sales %NM53.8-  
Imports to sales %NM16.4-  
Exports (fob) Rs mNA133,248 0.0%   
Imports (cif) Rs mNA40,615 0.0%   
Fx inflow Rs m0133,248 0.0%   
Fx outflow Rs m044,946 0.0%   
Net fx Rs m088,302 0.0%   
CASH FLOW
From Operations Rs m033,289 0.0%  
From Investments Rs mNA5,987 0.0%  
From Financial Activity Rs mNA-13,648 0.0%  
Net Cashflow Rs m025,831 0.0%  

Share Holding

Indian Promoters % 28.4 48.8 58.2%  
Foreign collaborators % 0.0 3.1 -  
Indian inst/Mut Fund % 1.0 37.9 2.5%  
FIIs % 0.0 21.4 -  
ADR/GDR % 0.0 0.0 -  
Free float % 71.6 48.2 148.7%  
Shareholders   1,478 341,568 0.4%  
Pledged promoter(s) holding % 0.0 24.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare RAYMED LABS With:   SUN PHARMA    LUPIN    CIPLA    DR. REDDYS LAB    CADILA HEALTHCARE    



Today's Market

Sensex, Nifty Recover from Day's Low to End Higher; Maruti Suzuki Hits New High Post Q3 Results(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (1QFY22); Net Profit Down 2.0% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (down 2.0% YoY). Sales on the other hand came in at Rs 57 bn (down 3.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

Here's an analysis of the annual report of AUROBINDO PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

Aurobindo Pharma's Stock Falls After Profits Decline 7% (Views On News)

Jun 1, 2021

Aurobindo Pharma shares fell nearly 4% after quarterly earnings disappoint.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

RAYMED LABS SHARE PRICE


Jan 24, 2022 (Close)

TRACK RAYMED LABS

  • Track your investment in RAYMED LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

RAYMED LABS - UNICK FIX-A-FORM AND PRINTERS COMPARISON

COMPARE RAYMED LABS WITH

MARKET STATS